The US and Canadian market for bariatric devices is growing at stunning rate, driven by an increasingly prevalent patient population, the increasing capability of physicians to perform bariatric procedures and a recognition by healthcare systems and third party payers to address the problem as a lynchpin for a condition that otherwise will drive up other, [...]
The formation of medical technology companies has proceeded at a steady pace over the past few years. These largely device-intensive companies are pursuing a range of clinical applications that is progressively more diverse, encompassing materials science, application of various hybrid technologies and, ultimately, often dissolving boundaries between devices, diagnostics, biotech, pharma and other traditional product [...]
Another sampling of new technologies in various stages of development at recently founded medical technology startups:
Surgical drain and other technologies
Novel wound healing and drug delivery based on unique hydrogel
Nitric oxide coatings for blood-contacting medical devices
Bioresorbable implants for a range of surgical applications
Device to block transmission of pathogens via intravenous catheters
Self-expanding stent for femoral and popliteal [...]
According to a study published in 2006 in the Journal of the American Medical Association (JAMA), despite increasing efforts over the last several years by government organizations, physicians, public health administrators and the media to stem the tide, obesity isn’t going away. The researchers found that the prevalence of overweight and obesity among children and [...]
Below is the coverage in the April 2008 issue of MedMarkets.
Ablation: An Energized Market
Demand for Hip and Knee Implants Expected to Increase
MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends
Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular
Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, IDev Technologies, IlluminOss [...]
The revenues to be had from the clinical management of obesity, whether derived from pharmaceutical or device sales, are forecast to see double-digit growth through 2015. Although revenues have been dampened by the FDA’s negative reaction to Sanofi-Aventis’ application for rimonabant, there are other drug compounds in late stages of testing which may prove to [...]
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
From the December 2007 edition of MedMarkets
Never before, or so it seems, have there been so many widely different dynamics in medical technology markets that determine whether a company will be successful, or if successful, to what degree. Science, its application in technology, and its commercialization in healthcare has traditionally been driven by a narrow [...]
A scary graphic showing the rapid progression of obesity in the U.S. was shown on CNN, illustrating the percent population by state that was obese (body mass index ³ 30) from 1985 to 2006.
This graphic coincides with the increasingly high percentage of populations globally that are obese. From report #S825, “Worldwide Obesity 2007″, we reference [...]
(From the September 2007 issue of MedMarkets)
Drawing upon the clinical and technology sectors we have addressed in MedMarkets and the Market and Technology Reports of MedMarket Diligence, we have previously identified a number of areas where we see substantial growth in medical technology markets. In our white paper, High Growth Medical Technologies, we note those [...]